These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 24838003)

  • 1. BET-ting on chromatin-based therapeutics for heart failure.
    Haldar SM; McKinsey TA
    J Mol Cell Cardiol; 2014 Sep; 74():98-102. PubMed ID: 24838003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BET bromodomains mediate transcriptional pause release in heart failure.
    Anand P; Brown JD; Lin CY; Qi J; Zhang R; Artero PC; Alaiti MA; Bullard J; Alazem K; Margulies KB; Cappola TP; Lemieux M; Plutzky J; Bradner JE; Haldar SM
    Cell; 2013 Aug; 154(3):569-82. PubMed ID: 23911322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A long noncoding RNA protects the heart from pathological hypertrophy.
    Han P; Li W; Lin CH; Yang J; Shang C; Nuernberg ST; Jin KK; Xu W; Lin CY; Lin CJ; Xiong Y; Chien H; Zhou B; Ashley E; Bernstein D; Chen PS; Chen HV; Quertermous T; Chang CP
    Nature; 2014 Oct; 514(7520):102-106. PubMed ID: 25119045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynamic Chromatin Targeting of BRD4 Stimulates Cardiac Fibroblast Activation.
    Stratton MS; Bagchi RA; Felisbino MB; Hirsch RA; Smith HE; Riching AS; Enyart BY; Koch KA; Cavasin MA; Alexanian M; Song K; Qi J; Lemieux ME; Srivastava D; Lam MPY; Haldar SM; Lin CY; McKinsey TA
    Circ Res; 2019 Sep; 125(7):662-677. PubMed ID: 31409188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathological Ace2-to-Ace enzyme switch in the stressed heart is transcriptionally controlled by the endothelial Brg1-FoxM1 complex.
    Yang J; Feng X; Zhou Q; Cheng W; Shang C; Han P; Lin CH; Chen HS; Quertermous T; Chang CP
    Proc Natl Acad Sci U S A; 2016 Sep; 113(38):E5628-35. PubMed ID: 27601681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphorylation of the chromatin remodeling factor DPF3a induces cardiac hypertrophy through releasing HEY repressors from DNA.
    Cui H; Schlesinger J; Schoenhals S; Tönjes M; Dunkel I; Meierhofer D; Cano E; Schulz K; Berger MF; Haack T; Abdelilah-Seyfried S; Bulyk ML; Sauer S; Sperling SR
    Nucleic Acids Res; 2016 Apr; 44(6):2538-53. PubMed ID: 26582913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systems proteomics of cardiac chromatin identifies nucleolin as a regulator of growth and cellular plasticity in cardiomyocytes.
    Monte E; Mouillesseaux K; Chen H; Kimball T; Ren S; Wang Y; Chen JN; Vondriska TM; Franklin S
    Am J Physiol Heart Circ Physiol; 2013 Dec; 305(11):H1624-38. PubMed ID: 24077883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic response to environmental stress: Assembly of BRG1-G9a/GLP-DNMT3 repressive chromatin complex on Myh6 promoter in pathologically stressed hearts.
    Han P; Li W; Yang J; Shang C; Lin CH; Cheng W; Hang CT; Cheng HL; Chen CH; Wong J; Xiong Y; Zhao M; Drakos SG; Ghetti A; Li DY; Bernstein D; Chen HS; Quertermous T; Chang CP
    Biochim Biophys Acta; 2016 Jul; 1863(7 Pt B):1772-81. PubMed ID: 26952936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-Resolution Mapping of Chromatin Conformation in Cardiac Myocytes Reveals Structural Remodeling of the Epigenome in Heart Failure.
    Rosa-Garrido M; Chapski DJ; Schmitt AD; Kimball TH; Karbassi E; Monte E; Balderas E; Pellegrini M; Shih TT; Soehalim E; Liem D; Ping P; Galjart NJ; Ren S; Wang Y; Ren B; Vondriska TM
    Circulation; 2017 Oct; 136(17):1613-1625. PubMed ID: 28802249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bromodomain and extra-terminal (BET) bromodomain inhibition activate transcription via transient release of positive transcription elongation factor b (P-TEFb) from 7SK small nuclear ribonucleoprotein.
    Bartholomeeusen K; Xiang Y; Fujinaga K; Peterlin BM
    J Biol Chem; 2012 Oct; 287(43):36609-16. PubMed ID: 22952229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcineurin/NFAT coupling participates in pathological, but not physiological, cardiac hypertrophy.
    Wilkins BJ; Dai YS; Bueno OF; Parsons SA; Xu J; Plank DM; Jones F; Kimball TR; Molkentin JD
    Circ Res; 2004 Jan; 94(1):110-8. PubMed ID: 14656927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BET bromodomain-targeting compounds reactivate HIV from latency via a Tat-independent mechanism.
    Boehm D; Calvanese V; Dar RD; Xing S; Schroeder S; Martins L; Aull K; Li PC; Planelles V; Bradner JE; Zhou MM; Siliciano RF; Weinberger L; Verdin E; Ott M
    Cell Cycle; 2013 Feb; 12(3):452-62. PubMed ID: 23255218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting the EWS-ETS transcriptional program by BET bromodomain inhibition in Ewing sarcoma.
    Hensel T; Giorgi C; Schmidt O; Calzada-Wack J; Neff F; Buch T; Niggli FK; Schäfer BW; Burdach S; Richter GH
    Oncotarget; 2016 Jan; 7(2):1451-63. PubMed ID: 26623725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The double bromodomain-containing chromatin adaptor Brd4 and transcriptional regulation.
    Wu SY; Chiang CM
    J Biol Chem; 2007 May; 282(18):13141-5. PubMed ID: 17329240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Signal-induced Brd4 release from chromatin is essential for its role transition from chromatin targeting to transcriptional regulation.
    Ai N; Hu X; Ding F; Yu B; Wang H; Lu X; Zhang K; Li Y; Han A; Lin W; Liu R; Chen R
    Nucleic Acids Res; 2011 Dec; 39(22):9592-604. PubMed ID: 21890894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic reprogramming via PPARα signaling in cardiac hypertrophy and failure: From metabolomics to epigenetics.
    Warren JS; Oka SI; Zablocki D; Sadoshima J
    Am J Physiol Heart Circ Physiol; 2017 Sep; 313(3):H584-H596. PubMed ID: 28646024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic modifications and noncoding RNAs in cardiac hypertrophy and failure.
    Greco CM; Condorelli G
    Nat Rev Cardiol; 2015 Aug; 12(8):488-97. PubMed ID: 25962978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting transcriptional machinery to inhibit enhancer-driven gene expression in heart failure.
    Minerath RA; Hall DD; Grueter CE
    Heart Fail Rev; 2019 Sep; 24(5):725-741. PubMed ID: 30972522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BET bromodomain inhibition suppresses innate inflammatory and profibrotic transcriptional networks in heart failure.
    Duan Q; McMahon S; Anand P; Shah H; Thomas S; Salunga HT; Huang Y; Zhang R; Sahadevan A; Lemieux ME; Brown JD; Srivastava D; Bradner JE; McKinsey TA; Haldar SM
    Sci Transl Med; 2017 May; 9(390):. PubMed ID: 28515341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of curcumin to heart failure therapy by targeting transcriptional pathway in cardiomyocytes.
    Katanasaka Y; Sunagawa Y; Hasegawa K; Morimoto T
    Biol Pharm Bull; 2013; 36(1):13-7. PubMed ID: 23302632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.